HIV researchers edge closer to a cure
British man with HIV hoping to be cured of the disease after unprecedented collaboration between universities
British scientists could be on the brink of finding a cure for HIV with a pioneering new therapy designed to eradicate the virus.
An unprecedented collaboration between the universities of Oxford, Cambridge, Imperial College London, University College London and King's College London is being backed by the NHS, which could save millions of pounds in reduced treatment costs.
How does it work?
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
The HIV virus infects T-cells, white blood cells that play an important role in the immune system. If the T-cell is active, the HIV virus multiplies to infect other T-cells – something that can be suppressed by anti-retroviral therapies (Art). However, Art is unable to target T-cells when they are not active, so only acts as a control for HIV rather than a cure.
The new therapy will target the HIV reservoir in these dormant cells, by first boosting the patient's immune system, allowing it to spot HIV-infected T-cells, and then using a drug to activate the dormant T-cells so they can be found and destroyed.
"This is the first therapy to track down and destroy the HIV in every part of the body, including in the dormant cells that evade current treatments", says the Sunday Times.
It's a "huge challenge", says Mark Samuels, the managing director of the National Institute for Health Research, and it is "still early days", but the progress has been "remarkable", he adds.
Will it work?
Laboratory tests have proved successful and scientists are now trying the therapy on their first patient, a 44-year-old British man.
Early tests show the virus is undetectable in the man's blood but he will have to wait some months before confirmation of whether the treatment has permanently cleared the disease.
Sign up for Today's Best Articles in your inbox
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
-
Covid might be to blame for an uptick in rare cancers
The explainer The virus may be making us more susceptible to certain cancers
By Devika Rao, The Week US Published
-
The alarming rise of cancer in young people
Under the radar Cancer rates are rising, and the cause is not clear
By Devika Rao, The Week US Published
-
US bans final type of asbestos
Speed Read Exposure to asbestos causes about 40,000 deaths in the U.S. each year
By Peter Weber, The Week US Published
-
'Beyond belief': fears of asbestos return
Under the radar Attention is returning to the dangers of the carcinogenic substance
By Chas Newkey-Burden, The Week UK Published
-
The contaminated blood scandal
The Explainer Widely regarded as the worst treatment disaster in the history of the NHS, the public inquiry is due to publish its report in May
By The Week UK Published
-
What to say to someone who has cancer
The Explainer Saying something is better than nothing but there are some things to avoid too
By Chas Newkey-Burden, The Week UK Published
-
Anastrozole: the daily breast cancer pill tipped to save thousands of lives
The Explainer Existing treatment approved for preventative use under 'pioneering' NHS drug repurposing scheme
By Harriet Marsden, The Week UK Published
-
Good health news: seven surprising medical discoveries made in 2023
In Depth A fingerprint test for cancer, a menopause patch and the shocking impacts of body odour are just a few of the developments made this year
By The Week Staff Published